Bibliographie (2530)
Characteristics associated with Multisystem Inflammatory Syndrome among adults with SARS-CoV-2 infection
jeudi, 20 mai 2021 13:28 Écrit par Zouhair SouissiCharacteristics Associated With Multisystem Inflammatory Syndrome Among Adults With SARS-CoV-2 Infection – JAMA Network Open Editorial: The Multisystem Inflammatory Syndrome in Adults With SARS-CoV-2 Infection—Another Piece of an Expanding Puzzle Commentary: COVID-related inflammatory syndrome looks different in adults – CIDRAP
The post Characteristics associated with Multisystem Inflammatory Syndrome among adults with SARS-CoV-2 infection appeared first on Links Medicus.
ERS clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years.
jeudi, 20 mai 2021 13:28 Écrit par Zouhair SouissiEuropean Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years – European Respiratory Journal
The post ERS clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years. appeared first on Links Medicus.
FDA In Brief: FDA advises against use of SARS-CoV-2 antibody test results to evaluate immunity or protection from COVID-19, including after vaccination.
jeudi, 20 mai 2021 13:28 Écrit par Zouhair SouissiFDA In Brief: FDA Advises Against Use of SARS-CoV-2 Antibody Test Results to Evaluate Immunity or Protection From COVID-19, Including After Vaccination – U.S. Food & Drug Administration Commentary on Twitter (thread – click for more) Today, we issued a safety communication notifying the public and providers that results from SARS-CoV-2 antibody tests should […]
The post FDA In Brief: FDA advises against use of SARS-CoV-2 antibody test results to evaluate immunity or protection from COVID-19, including after vaccination. appeared first on Links Medicus.
Systematic review and meta-analysis of observational studies suggest low-dose aspirin may be of benefit for patients with Covid-19 – the finds require further investigation in randomized studies.
jeudi, 20 mai 2021 13:28 Écrit par Zouhair SouissiActive Prescription of Low-dose Aspirin During or Prior to Hospitalization and Mortality in COVID-19 — A Systematic Review and Meta-analysis of Adjusted Effect Estimates – International Journal of Infectious Diseases
The post Systematic review and meta-analysis of observational studies suggest low-dose aspirin may be of benefit for patients with Covid-19 – the finds require further investigation in randomized studies. appeared first on Links Medicus.
Cohort study: 14% of adults aged 65 years or less who were infected with SARS-CoV-2 had at least one new type of clinical sequelae that required medical care after the acute phase of the illness.
jeudi, 20 mai 2021 13:28 Écrit par Zouhair SouissiRisk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study – The BMJ Editorial: Unpacking post-covid symptoms – The BMJ Commentary on Twitter (thread – click for more) After covid infections, 14% of >266,000 people, age ≤ 65, developed at least 1 sequelae that required medical care #LongCovid Just out […]
The post Cohort study: 14% of adults aged 65 years or less who were infected with SARS-CoV-2 had at least one new type of clinical sequelae that required medical care after the acute phase of the illness. appeared first on Links Medicus.
One year after hospital discharge due to SARS-CoV-2 Infection, the prevalence of long-term cough, chest pain, dyspnea, and fatigue was 2.5%, 6.5%, 23.3%, and 61.2%, respectively
jeudi, 20 mai 2021 13:28 Écrit par Zouhair SouissiPrevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study – Lung
The post One year after hospital discharge due to SARS-CoV-2 Infection, the prevalence of long-term cough, chest pain, dyspnea, and fatigue was 2.5%, 6.5%, 23.3%, and 61.2%, respectively appeared first on Links Medicus.
WHO Solidarity trial to restart with focus on drugs that act on immune responses caused by Covid-19.
mercredi, 19 mai 2021 10:56 Écrit par Zouhair SouissiInternational COVID-19 trial to restart with focus on immune responses – Nature
The post WHO Solidarity trial to restart with focus on drugs that act on immune responses caused by Covid-19. appeared first on Links Medicus.
![[Preprint] RECOVERY Trial: Colchicine does not improve outcomes in patients admitted to hospital with COVID-19.](/media/k2/items/cache/3ae7ed6dc1e285ef778f4f2d7f0bc247_S.jpg)
[Preprint] RECOVERY Trial: Colchicine does not improve outcomes in patients admitted to hospital with COVID-19.
mercredi, 19 mai 2021 10:56 Écrit par Zouhair SouissiColchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv Commentary on Twitter (thread – click for more) RECOVERY pre-print: Colchicine 11340 patients hospitalised with COVID-19 Randomised to colchicine vs usual care No significant improvement in:– 28-day mortality– discharge alive at 28 days– progression to invasive mechanical […]
The post [Preprint] RECOVERY Trial: Colchicine does not improve outcomes in patients admitted to hospital with COVID-19. appeared first on Links Medicus.
Systematic review: Treatment of gastro-esophageal reflux disease to help manage asthma in adults and children may result in reduced use of rescue medications, but the benefits on the number of exacerbations and hospital utilization remain uncertain.
mardi, 18 mai 2021 14:39 Écrit par Zouhair SouissiPharmacological and surgical interventions for the treatment of gastro‐oesophageal reflux in adults and children with asthma – Cochrane Library Summary: Treatment of gastro-oesophageal reflux disease to help manage asthma in adults and children – Cochrane Library
The post Systematic review: Treatment of gastro-esophageal reflux disease to help manage asthma in adults and children may result in reduced use of rescue medications, but the benefits on the number of exacerbations and hospital utilization remain uncertain. appeared first on Links Medicus.
M-A: Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis – The incidence and mortality in the ICU were estimated to be 10.2% and 54.9%, respectively.
mardi, 18 mai 2021 14:39 Écrit par Zouhair SouissiIncidence and mortality of COVID‐19‐associated pulmonary aspergillosis: A systematic review and meta‐analysis – Mycoses
The post M-A: Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis – The incidence and mortality in the ICU were estimated to be 10.2% and 54.9%, respectively. appeared first on Links Medicus.
